Roflumilast: In Chronic Obstructive Pulmonary Disease

By Sanford Mark  

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1615-1627

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Modelling of Roflumilast and Roflumilast N-Oxide by Total Phosphodiesterase-4 Inhibitory Activity and Development of a Population Pharmacodynamic-Adverse Event Model

By Lahu Gezim   Hünnemeyer Andreas  

Clinical Pharmacokinetics, Vol. 49, Iss. 9, 2010-09 ,pp. : 589-606

Adis International

Access to resources Recommend Favorite

Roflumilast: a guide to its use in chronic obstructive pulmonary disease

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 9, 2011-09 ,pp. : 6-10

Adis International

Access to resources Recommend Favorite

Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease

By Giembycz Mark A  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1361-1379

Informa Healthcare

Access to resources Recommend Favorite

A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease

By Mölken Maureen P.M.H. Rutten-van  

PharmacoEconomics, Vol. 25, Iss. 8, 2007-01 ,pp. : 695-711

Adis International

Access to resources Recommend Favorite